This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

24-Hour Secretion of Corticotropin and Cortisol

James L. Abelson, MD, PhD; George C. Curtis, MD

Arch Gen Psychiatry. 1996;53(4):323-331.

Abstract
Background
Oversecretion of corticotropin-releasing hormone and/or dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis may contribute to patho-physiologic processes in panic disorder, but documentation of HPA axis disturbance in panic has been inconsistent. In the current study we examined HPA axis activity in panic disorder over a full circadian cycle, using frequent blood sampling to provide detailed assessment of corticotropin and cortisol secretion.

Methods
Twenty patients with panic disorder and 12 normal control subjects were studied. Blood samples were drawn every 15 minutes for 24 hours and assayed for corticotropin and cortisol levels.

Results
Patients with panic disorder had elevated overnight cortisol secretion and greater amplitude of ultradian secretory episodes. Patients who entered the study through clinical referral channels had greater cortisol secretion than those recruited by advertisements. Patients with panic disorder who had a low frequency of panic attacks had elevated daytime corticotropin levels and elevated corticotropin ultradian amplitude. Patients with a high frequency of attacks had shifted corticotropin circadian cycles.

Conclusions
Patients with panic disorder demonstrate subtle alterations in HPA axis activity, characterized by overnight hypercortisolemia and increased activity in ultradian secretory episodes, but HPA axis alterations in panic are modulated by illness severity and treatment seeking. It remains unclear whether HPA axis dysregulation in panic represents a pathogenic defect within the axis itself. Inconsistencies in prior work may reflect the subtlety of the abnormalities seen, differences in clinical characteristics of patients studied, and the use of different probes and measurement contexts.

Author Affiliations
From the Anxiety Disorders Program, Department of Psychiatry, University of Michigan, Ann Arbor.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Modeling a Negative Response Bias in the Human Amygdala by Noradrenergic-Glucocorticoid Interactions
Kukolja et al.
J. Neurosci. 2008;28:12868-12876.
ABSTRACT | FULL TEXT  

Angiotensin-II Is a Putative Neurotransmitter in Lactate-Induced Panic-Like Responses in Rats with Disruption of GABAergic Inhibition in the Dorsomedial Hypothalamus
Shekhar et al.
J. Neurosci. 2006;26:9205-9215.
ABSTRACT | FULL TEXT  

Cognitive Modulation of the Endocrine Stress Response to a Pharmacological Challenge in Normal and Panic Disorder Subjects
Abelson et al.
Arch Gen Psychiatry 2005;62:668-675.
ABSTRACT | FULL TEXT  

24-Hour Pituitary and Adrenal Hormone Profiles in Chronic Fatigue Syndrome
Di Giorgio et al.
Psychosom. Med. 2005;67:433-440.
ABSTRACT | FULL TEXT  

Interstitial Cystitis and Panic Disorder: A Potential Genetic Syndrome
Weissman et al.
Arch Gen Psychiatry 2004;61:273-279.
ABSTRACT | FULL TEXT  

Salivary Cortisol Response During Exposure Treatment in Driving Phobics
Alpers et al.
Psychosom. Med. 2003;65:679-687.
ABSTRACT | FULL TEXT  

The Neuroendocrinology of Chronic Fatigue Syndrome
Cleare
Endocr. Rev. 2003;24:236-252.
ABSTRACT | FULL TEXT  

Human Glucocorticoid Feedback Inhibition Is Reduced in Older Individuals: Evening Study
WILKINSON et al.
J. Clin. Endocrinol. Metab. 2001;86:545-550.
ABSTRACT | FULL TEXT  

Decreased Brain GABAA-Benzodiazepine Receptor Binding in Panic Disorder: Preliminary Results From a Quantitative PET Study
Malizia et al.
Arch Gen Psychiatry 1998;55:715-720.
ABSTRACT | FULL TEXT